Category:

Medications like buprenorphine and naltrexone have been proven to reduce cravings and withdrawal symptoms in people with opioid use disorder...Pharmacists in Nevada will soon be able to prescribe medications designed to help opioid addiction...The regulation, R059-23, was approved...by the Legislative Commission, a 11-member bipartisan board of legislators that gives final stamps of approval on regulations established by executive branch agencies and boards. State Sen. Lisa Krasner, R-Reno, cast the only vote in opposition...The change is the result of Assembly Bill 156, which passed the Nevada State Legislature with unanimous support last year...READ MORE

The Alabama Attorney General’s office is investigating the Alabama Pharmacy Board after it revoked the license of a north Alabama pharmacist for working without permission after a felony conviction...Attorney General Steve Marshall’s office dismissed the board’s case against pharmacist Billy Flint East, whose license was taken in March...“Credible allegations have been made about the handling of this matter by employees of the State Board of Pharmacy, which are now under investigation by the Attorney General’s Office,” said the state order...Marshall’s office similarly dismissed the board’s case against East’s current employer, Brooklere Pharmacy, after the Pharmacy Board alleged it did not seek legal approval for East to practice after his conviction...READ MORE

Cannabis is illegal federally – classified as a Schedule I controlled substance – but even state law, despite cannabis being legal to use in Nevada, maintains cannabis as a Schedule I drug alongside methamphetamine, heroin and cocaine...The Nevada State Board of Pharmacy continues to list cannabis as a Schedule I substance, and that listing prompted a lawsuit this week by the ACLU of Nevada seeking to get cannabis removed from the list...“For cannabis to be classified as a Schedule I substance, the Board of Pharmacy must find that it has no accepted medical use in treatment or it cannot be safely distributed to the public,” ACLU representatives said. “However, the Nevada Constitution explicitly allows for the ‘use by a patient, upon the advice of his physician, of a plant of the genus Cannabis for the treatment or alleviation of cancer, glaucoma, acquired immunodeficiency syndrome… or other chronic or debilitating medical conditions.’”...The ACLU alleges the pharmacy board’s classification continues to waste taxpayer dollars by continuing criminal convictions against those using and possessing cannabis...READ MORE

Nevada will become one of the first states to allow pharmacists to prescribe human immunodeficiency virus prevention drugs to patients at risk of contracting the virus, as the state works to combat one of the highest rates of HIV diagnoses in the country...A bill signed by Gov. Steve Sisolak on June 6 authorizes pharmacists with sufficient liability coverage to prescribe, dispense and administer HIV prevention drugs — including post-exposure prophylaxis to people who may have come into contact with HIV and pre-exposure prophylaxis for people at risk — without a prescription from a practitioner starting as early as Oct. 1, in accordance with protocols to be developed by the State Board of Pharmacy over the next several months...READ MORE

Nevada Supreme Court justices are weighing arguments in a lawsuit that seeks to remove the Nevada Board of Pharmacy from its administrative role in regulating cannabis...The ACLU of Nevada originally filed the case in 2022 on behalf of the Cannabis Equity & Inclusion Community, a nonprofit group that advocates for policies beneficial to Nevada’s legal cannabis community, in Clark County District Court arguing the pharmacy board’s classification of cannabis as a Schedule I drug was unconstitutional...District Judge Joe Hardy ruled in favor of the ACLU, determining the pharmacy board’s classification as unconstitutional, but the board appealed the decision to the state’s top court. Arguments were heard Tuesday; it’s unknown when a decision will be handed down...READ MORE

MenACWY 12th Grade Requirement
What Is the Meningococcal Vaccine and Why Is It Important?
What Does This Mean for Nevada?
What Does This Mean for Pharmacists?
12th Grade MenACWY Vaccination Requirement Resources

Electronic Prescribing Mandate for Controlled SubstancesNevada Revised Statutes (NRS) 639.23535 requires that all controlled substance (CS) prescriptions must be transmitted to a pharmacy by electronic prescribing (e-prescribing). While NRS 639.23535 took effect on January 1, 2021, the Nevada State Board of Pharmacy provided an exemption for practitioners by regulation.The law mandated that this exemption would expire on December 31, 2021...READ MORE

After more than two decades of violating state law, the Nevada Board of Pharmacy must remove cannabis from a list of controlled substances deemed to be highly abused, a Clark County District Court judge ruled...The order followed a lawsuit brought forward in April by the Cannabis, Equity and Inclusion Community on behalf of Antoine Poole, a Las Vegas resident who was convicted of felony possession of a controlled substance for marijuana in 2017. The conviction occurred the same year recreational marijuana use became legal in Nevada...READ MORE

Self-Administered Hormonal Contraceptives Dispensed Without a Prescription

Senate Bill (SB) 190 was passed during the 2021 legislative session. The language to the bill can be located here. SB 190 permits a pharmacist to dispense a self-administered hormonal contraceptive to a patient under a protocol established by regulation by the Nevada State Board of Pharmacy without a prescription from a practitioner.

Nevada Medicaid Fee-for-Service Transition of Pharmacy Benefits Management to Magellan Medicaid Administration, Inc

On July 1, 2022, Magellan Medicaid Administration, Inc, (MMA) will assume the administrative operation of pharmacy benefits management on behalf of the state of Nevada Department of Health and Human Services, Division of Health Care Financing and Policy for the Nevada Medicaid fee-for-service...READ MORE

• Practice Guidelines for the Administration of Buprenorphine for Treating OUD
• Resumption of In-person Inspections
• New Law CE
• Inspector RetiredPharmacy Inspector
  Joe “Batman” Depczynski
• New Board Investigator/Inspector
  Monica S. Segedy
  Mui Lee, RPh,